Filing metadata

Accession number
0001209191-21-043447
Form type
Form 3
Filer
Kinnate Biopharma Inc.
CIK
CIK 1797768
Filed
Jun 28, 2021
Reporting period
Jun 24, 2021
Description
Initial ownership

Explore SEC Filings Hub